Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Abiomed Inc.

    NASDAQ: ABMD · Real-Time Price · USD
    381.02
    0.00 (0.00%)
    At close: Dec 21, 2022, 10:00 PM

    Abiomed Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
    Revenue
    		 265.92M 277.15M 269.85M 261.18M 248.14M 252.59M 241.25M 231.66M 209.76M 164.85M
    Cost of Revenue
    		 48.88M 52.63M 51.46M 47.63M 43.89M 45.19M 46.08M 41.11M 38.74M 35.98M
    Gross Profit
    		 217.04M 224.52M 218.39M 213.55M 204.26M 207.4M 195.17M 190.55M 171.03M 128.87M
    Operating Income
    		 57.99M 66.05M 65M 64.57M 60.44M -49.28M 62.8M 71.35M 61.34M 34.07M
    Interest Income
    		 80.71M 3.77M 9.76M n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 138.7M 69.82M 74.76M 57.88M 67.27M -9.35M 73.49M 80.73M 72.92M 61.08M
    Net Income
    		 106.13M 54.55M 60.33M 45.75M 56.95M -26.52M 56.86M 61.87M 62.21M 44.59M
    Selling & General & Admin
    		 116.96M 118M 109.61M 107.62M 102.78M 103.48M 100.37M 86.2M 79.17M 68.44M
    Research & Development
    		 42.09M 40.48M 43.78M 40.87M 41.04M 37.71M 31.99M 33M 30.52M 26.36M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 159.05M 158.47M 153.39M 148.49M 143.82M 141.19M 132.36M 119.2M 109.69M 94.8M
    Interest Expense
    		 80.71M 3.77M 9.76M n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 207.93M 211.1M 204.85M 196.11M 187.71M 186.38M 178.44M 160.31M 148.43M 130.78M
    Income Tax Expense
    		 32.57M 15.27M 14.44M 12.13M 10.32M 17.18M 16.64M 18.87M 10.7M 16.49M
    Shares Outstanding (Basic)
    		 45.37M 45.58M 45.52M 45.51M 45.44M 45.31M 45.25M 45.2M 45.1M 45.01M
    Shares Outstanding (Diluted)
    		 45.71M 45.92M 45.95M 45.92M 45.89M 45.31M 45.78M 45.71M 45.66M 45.55M
    EPS (Basic)
    		 2.34 1.20 1.33 1.01 1.25 -0.59 1.26 1.37 1.38 0.99
    EPS (Diluted)
    		 2.32 1.19 1.31 1.00 1.24 -0.59 1.24 1.35 1.36 0.98
    EBITDA
    		 64.72M 72.67M 75.21M 71.59M 66.42M 187.55M 68.58M 76.04M 65.17M 37.15M
    EBIT
    		 219.41M 73.59M 84.52M 64.57M n/a n/a n/a n/a n/a n/a
    Depreciation & Amortization
    		 6.72M 6.62M 7.29M 6.93M 6.97M 6.91M 6.83M 6.13M 5.66M 5.48M

    Add to Watchlist